Company Directory / research

PrivateFor profitresearchSingapore, Singapore
Lion TCR is a clinical-stage biotechnology company.
Size
11-50 people: larger than 33% of companies with a size listed
Age
11 years old.
Reach
Website ranked #9,260,234 in the world for traffic, about 419 visits a month.
BiotechnologyHealth CareHealth DiagnosticsTherapeutics
Funding, as listed
$62M currency not stated
What the source datasets report. We have not watched these rounds ourselves.
Everything the source datasets list about Lion TCR, field by field. Contact details are held but never shown.
The company
Where
Size and reach
Funding, as listed
About this record
Growth, as the source summarises it
Lion TCR may be growing as it has formed a partnership with MaxCyte to support the global expansion of its TCR-T cell pipeline, indicating a strategic move to enhance its operational reach. This collaboration suggests an increase in the company's developmental capabilities and potential market presence. Furthermore, the fact that Lion TCR is mentioned in an article discussing T cell receptor therapy companies to watch implies that it is gaining recognition in its field, which can be a qualitative indicator of growth.
Summaries written by the source dataset, not by us, and not checked.
research in Singapore.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 17,167 companies in Singapore and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.